Recce Pharmaceuticals (PK)【RECEF】銘柄情報

Recce Pharmaceuticals (PK) (RECEF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.22

( - )

買値

0.22

売値

0.22

出来高

0.00 日の範囲 0.00

0.22 52 週間の範囲 0.22

時価総額

63.62M

前日終値

0.22

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 96,839

発行済株式数

289,183,422

配当利回り

PER

-4.5

1 株当たり利益 (EPS)

-0.11

歳入

974.56k

純利益

-30.25M

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States. The company’s lead candidate is RECCE 327 (R327) for the treatment of life-threatening bacterial infections. In addition, its product pipeline compris... Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States. The company’s lead candidate is RECCE 327 (R327) for the treatment of life-threatening bacterial infections. In addition, its product pipeline comprises R327 Intravenous, which is in Phase I and Phase I/II clinical trial for the treatment of urinary tract infections/urosepsis; and R327 Topical Gel, which is Phase II clinical trial for the treatment of acute bacterial skin and skin structure infections, as well as is in Phase I/II clinical trials for topical wound infections and diabetic foot infections. The company has strategic partnership with Murdoch Children’s Research Institute for development of the Acinetobacter baumannii and Mycobacterium abscessus; and cooperative research and development agreement with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to be tested against highly hazardous pathogens. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.recce.com.au

本社

Sydney, Australia

設立

2026

Recce Pharmaceuticals (PK) is listed in the Healthcare sector of the その他OTC with ticker RECEF. The last closing price for Recce Pharmaceuticals (PK) was US$0.22. Over the last year, Recce Pharmaceuticals (PK) shares have traded in a share price range of US$ 0.22 to US$ 0.22.

Recce Pharmaceuticals (PK) currently has 289,183,422 shares in issue. The market capitalisation of Recce Pharmaceuticals (PK) is US$63.62 million. Recce Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of -4.50.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.22	0.22	0.22	0	0	CS
26	0	0	0.22	0.22	0.22	0	0	CS
52	0	0	0.22	0.22	0.22	263	0.22	CS
156	-0.241	-52.2776572668	0.461	0.6	0.22	788	0.4551769	CS
260	-0.38	-63.3333333333	0.6	0.6	0.22	770	0.46087411	CS